178 related articles for article (PubMed ID: 2317905)
1. Effect of intravenous propranolol on coronary vasomotion at rest and during dynamic exercise in patients with coronary artery disease.
Bortone AS; Hess OM; Gaglione A; Suter T; Nonogi H; Grimm J; Krayenbuehl HP
Circulation; 1990 Apr; 81(4):1225-35. PubMed ID: 2317905
[TBL] [Abstract][Full Text] [Related]
2. [Effect of intracoronary and intravenous administration of propranolol on coronary vasomotility at rest and during exercise].
Bortone A; Hess OM; Gaglione A; Locuratolo N; Troito G; Rizzon P; Chiddo A
Cardiologia; 1989 Aug; 34(8):679-88. PubMed ID: 2605578
[TBL] [Abstract][Full Text] [Related]
3. Effect of intracoronary and intravenous propranolol on human coronary arteries.
Hess OM; Bortone A; Gaglione A; Nonogi H; Grimm J; Krayenbuehl HP
Eur Heart J; 1989 Nov; 10 Suppl F():153-8. PubMed ID: 2620682
[TBL] [Abstract][Full Text] [Related]
4. Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease.
Gaglione A; Hess OM; Corin WJ; Ritter M; Grimm J; Krayenbuehl HP
J Am Coll Cardiol; 1987 Aug; 10(2):299-310. PubMed ID: 3110237
[TBL] [Abstract][Full Text] [Related]
5. Coronary stenosis vasomotion during dynamic exercise before and after PTCA.
Suter TM; Hess OM; Bortone A; Nonogi H; Grimm J; Krayenbuehl HP
Eur Heart J; 1989 Dec; 10 Suppl G():58-63. PubMed ID: 2627951
[TBL] [Abstract][Full Text] [Related]
6. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine.
Kaufmann P; Vassalli G; Utzinger U; Hess OM
J Am Coll Cardiol; 1995 Sep; 26(3):624-31. PubMed ID: 7642851
[TBL] [Abstract][Full Text] [Related]
7. Normalization of coronary vasomotion after percutaneous transluminal coronary angioplasty?
Suter TM; Buechi M; Hess OM; Haemmerli-Saner C; Gaglione A; Krayenbuehl HP
Circulation; 1992 Jan; 85(1):86-92. PubMed ID: 1728488
[TBL] [Abstract][Full Text] [Related]
8. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.
Gage JE; Hess OM; Murakami T; Ritter M; Grimm J; Krayenbuehl HP
Circulation; 1986 May; 73(5):865-76. PubMed ID: 3084124
[TBL] [Abstract][Full Text] [Related]
9. The poststenotic vessel segment during dynamic exercise: effect of oral isosorbide-dinitrate.
Gaglione A; Hess OM; Haemmerli C; Suter T; Kirkeeide RL; Osenberg HP; Muser M; Anliker M; Gould KL; Krayenbuehl HP
Basic Res Cardiol; 1990; 85 Suppl 1():347-57. PubMed ID: 2091610
[TBL] [Abstract][Full Text] [Related]
10. Prevention of coronary vasoconstriction by diltiazem during dynamic exercise in patients with coronary artery disease.
Nonogi H; Hess OM; Ritter M; Bortone A; Corin WJ; Grimm J; Krayenbuehl HP
J Am Coll Cardiol; 1988 Oct; 12(4):892-9. PubMed ID: 3417988
[TBL] [Abstract][Full Text] [Related]
11. Coronary vasomotor tone during static and dynamic exercise.
Hess OM; Bortone A; Eid K; Gage JE; Nonogi H; Grimm J; Krayenbuehl HP
Eur Heart J; 1989 Nov; 10 Suppl F():105-10. PubMed ID: 2515965
[TBL] [Abstract][Full Text] [Related]
12. Diltiazem alone and combined with nitroglycerin: effect on normal and diseased human coronary arteries.
Hess OM; Nonogi H; Bortone A; Gage JE; Grimm J; Krayenbuehl HP
Eur Heart J; 1989 Nov; 10 Suppl F():142-6. PubMed ID: 2515968
[TBL] [Abstract][Full Text] [Related]
13. [Coronary vasomotor activity; its significance for the therapy of angina pectoris].
Hess OM; Nonogi H; Grimm J; Krayenbühl HP
Schweiz Med Wochenschr; 1988 Apr; 118(14):502-7. PubMed ID: 3131874
[TBL] [Abstract][Full Text] [Related]
14. Alpha-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries.
Julius BK; Vassalli G; Mandinov L; Hess OM
J Am Coll Cardiol; 1999 May; 33(6):1499-505. PubMed ID: 10334414
[TBL] [Abstract][Full Text] [Related]
15. Abnormal coronary vasomotion during exercise in patients with normal coronary arteries and reduced coronary flow reserve.
Bortone AS; Hess OM; Eberli FR; Nonogi H; Marolf AP; Grimm J; Krayenbuehl HP
Circulation; 1989 Mar; 79(3):516-27. PubMed ID: 2492909
[TBL] [Abstract][Full Text] [Related]
16. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension.
Frielingsdorf J; Seiler C; Kaufmann P; Vassalli G; Suter T; Hess OM
Circulation; 1996 Apr; 93(7):1380-7. PubMed ID: 8641027
[TBL] [Abstract][Full Text] [Related]
17. Abnormal coronary vasomotion in hypertension: role of coronary artery disease.
Frielingsdorf J; Kaufmann P; Seiler C; Vassalli G; Suter T; Hess OM
J Am Coll Cardiol; 1996 Oct; 28(4):935-41. PubMed ID: 8837571
[TBL] [Abstract][Full Text] [Related]
18. [Abnormal coronary vasomotility in subjects with normal coronary arteries and reduced reserve of coronary flow].
Bortone A; Hess OM; Gaglione A; Locuratolo N; Musci S; Sebastiani M; Rizzon P; Chiddo A
Cardiologia; 1989 Jan; 34(1):33-46. PubMed ID: 2720712
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced coronary artery vasodilation is not impaired by stent placement.
Maier W; Windecker S; Küng A; Lütolf R; Eberli FR; Meier B; Hess OM
Circulation; 2002 May; 105(20):2373-7. PubMed ID: 12021223
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transluminal coronary angioplasty reverses vasoconstriction of stenotic coronary arteries in hypertensive patients.
Frielingsdorf J; Kaufmann P; Suter T; Hug R; Hess OM
Circulation; 1998 Sep; 98(12):1192-7. PubMed ID: 9743510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
